Skip to main content

Table 2 Clinicopathological characteristics of breast cancer patients in our collective

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

  

n (%)

Age

<median

105(50%)

>median

105(50%)

Tumor grade

1

7(3,50%)

2

92(45,80%)

3

102(50,70%)

Tumor size

pT1

88(46,60%)

pT2

78(41,30%)

pT3/4

23(12,20%)

Lymph node status

pN0

119(57,50%)

pN1/2/3

88(42,50%)

Histological type

ductal

75(58,10%)

lobular

16(12,40%)

other

38(29,40%)

ER/PR status

negative

58(28,40%)

positive

146(71,60%)

HER2/neu

0

54(28,60%)

1

84(44,40%)

2

11(5,80%)

3

40(21,20%)